Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis. - Wikidata - awgldk - TriplyDB

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

http://www.wikidata.org/entity/Q47952113

about

Genetic complexity of the human innate host defense molecules, surfactant protein A1 (SP-A1) and SP-A2--impact on function Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients.Early pulmonary inflammation and lung damage in children with cystic fibrosis Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems.Surfactant proteins SP-B and SP-C and their precursors in bronchoalveolar lavages from children with acute and chronic inflammatory airway disease.Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome Surfactant protein D in human lung diseases.Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients.Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants.Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant.Liquid plug propagation in flexible microchannels: A small airway model.Surfactant protein D: a lung specific biomarker in COPD?Pulmonary surfactant: an immunological perspective.Lipids in cystic fibrosis.Surfactant proteins in pediatric interstitial lung disease.NET balancing: a problem in inflammatory lung diseases.Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study.Increased arginase activity in cystic fibrosis airways.Cystic fibrosis, pediatrics, control of breathing, pulmonary physiology and anatomy, and surfactant biology in AJRCCM in 2004.Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic Fibrosis

P2860

Q24620050-A6715E60-DCE3-4F4B-AA7E-1D4E32889D43 Q24815739-9AE12734-E089-462C-89FD-CDBE045B9346 Q27027040-A84B1B56-4ACF-4BBF-8344-3EABDF3B2B4C Q28280608-BD445C22-D81A-4B79-8255-73F798E38C02 Q30494364-E0C2476B-FF99-4BF8-98F9-869905FB923B Q33327761-945356E8-78C8-4468-82C6-0AA839F13CF5 Q33413056-836B0A76-5623-4A4D-84B2-EAE691D996CF Q34510708-E388429F-A940-43F8-B3B1-0BB419C858CE Q34567354-0BE4E82F-B327-45FC-818E-4283245248C6 Q35574274-D983072C-7445-4181-BAA1-6E542EACCC13 Q35689470-A4C7EBC8-B3DA-499A-8759-BDBFB61BC96E Q36310645-E1AA06F7-5D30-4836-9C2E-C7AA4C285E87 Q37315251-E776F1BD-85E8-4685-9619-CBC2FE218041 Q37362594-EF61E5AC-9179-40BD-ACA5-F61C7A428A9B Q37669627-F1097945-21AF-4D73-BD87-7655C804ACC5 Q37920895-E402943E-8DE5-4F99-92F9-51C850B56C55 Q40997138-8899728D-8B6F-4DE2-8F38-86596B45DD5F Q42947423-29E9C747-3B71-4A58-B1A1-31AA17982A5F Q45354070-C8F0BB74-92C7-463C-BFE7-5D994807D22D Q46706389-8494B14A-D421-40B3-B210-A0C0CAE8A936 Q47836713-BBA52671-BE63-4951-BEF5-6B2A1FDF3D8F Q58586433-305B39E0-775C-47C3-AAF6-784F7C85A40C

P2860

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

http://www.wikidata.org/entity/Q47952113

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

@en

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

@nl

type

label

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

@en

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

@nl

prefLabel

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

@en

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

@nl

P1433

Q47952113-EAA32797-1592-40A0-BD08-813836121B68

P1476

Q47952113-53E3A603-604B-47F6-87BF-7B8DDF4EE2F0

P2093

Q47952113-03CB88C2-3875-478E-BF47-7792CBA05FC5

Q47952113-1BA9A0BE-B60C-4442-AE0D-7578F2FCABB7

Q47952113-2F5087E8-D65D-4ACF-93B9-D08DBC32F90A

Q47952113-4A5BA9EE-8294-4D7B-B1B9-11DC96118079

Q47952113-61517DB8-B3EB-4324-8C40-0D3575599C65

Q47952113-64A9201C-0BC0-41CE-B8BD-633D3D17D3CF

Q47952113-948416D1-0339-476D-9AF1-F76FF1BF6661

P2860

Q47952113-08969F4D-0AE6-4D8E-9A45-ABBBEC57025B

Q47952113-0CB3E6CC-4715-4D7C-8878-ECEA036DB450

Q47952113-178A77E7-3D78-4598-BFCB-41B4FAFD7766

Q47952113-1D1D8DF6-22D3-4E23-80A0-997938C1D9E5

Q47952113-23349606-4B9D-4350-899A-CC67F5BE4F81

Q47952113-31259624-C897-48EE-A056-E93A7A98E057

Q47952113-5A040D77-2894-4ED3-A9FB-A3F797A30970

Q47952113-71F6E003-76A8-42AC-BEF4-86BF58137336

Q47952113-723B15F5-2B50-4833-84E6-D2F8EECEA2B4

Q47952113-90778C20-7A18-4C83-8BC8-7409C5F53BE1

P304

Q47952113-36E6DA90-3716-41D6-971B-12CBCBD263D5

P31

Q47952113-F7EEA495-C662-46D3-AD5F-517B60A85897

P356

Q47952113-06F61831-E4D9-4240-A401-9D28E49DA4B8

P407

Q47952113-0A3B84F6-7142-4FD4-9B25-7102C67E6247

P433

Q47952113-C203FCE9-DCC4-4220-BBFA-9F4A656DC0BE

P478

Q47952113-CCB6EE79-7C7E-4FAC-BF8B-4E6FD4AAEAD9

P50

Q47952113-EEBB4625-6251-4CC7-B28B-6C9B641DE6C5

P577

Q47952113-58BCC467-4170-4804-A4B7-94D40E21CFC3

P5875

Q47952113-6CBD2730-F280-437C-9F9F-BEE3029B1679

P698

Q47952113-E3931532-E18B-4E37-B373-379AB8F1B0A8

P921

Q47952113-90349D5E-16EB-401F-89CE-5FECE07B6792

P356

RCCM.200405-575OC

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis.

@en

P2093

BEAT Study Group

http://www.w3.org/2001/XMLSchema#string

Ernst Rietschel

http://www.w3.org/2001/XMLSchema#string

Karl Paul

http://www.w3.org/2001/XMLSchema#string

Manfred Ballmann

http://www.w3.org/2001/XMLSchema#string

Matthias Griese

http://www.w3.org/2001/XMLSchema#string

Reinhold Schmidt

http://www.w3.org/2001/XMLSchema#string

Robert Essl

http://www.w3.org/2001/XMLSchema#string

P2860

Collectins and pulmonary host defense

Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection

By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation

Pulmonary surfactant in health and human lung diseases: state of the art.

Pulmonary surfactant: functions, abnormalities and therapeutic options.

Pathophysiology and management of pulmonary infections in cystic fibrosis.

"Small airways disease" in children: no test is best.

Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates.

Surfactant protein A and D differently regulate the immune response to nonmucoid Pseudomonas aeruginosa and its lipopolysaccharide.

An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid.

P304

1000-1005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.200405-575OC

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8437386

http://www.w3.org/2001/XMLSchema#string

P698

15271694

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis